Investment Summary

Octopus Investments and YFM Equity Partners Invest In KeTech

On August 14, 2009, asset manager Octopus Investments and private equity firm YFM Equity Partners invested in technology hardware company KeTech

Investment Highlights
  • This is Octopus Investments’ 2nd and YFM Equity Partners’ 1st transaction in the Technology Hardware sector.
  • This is Octopus Investments’ 21st and YFM Equity Partners’ 22nd transaction in the United Kingdom.

Investment Summary

Date 2009-08-14
Target KeTech
Sector Technology Hardware
Investor(s) Octopus Investments
YFM Equity Partners
Deal Type Growth Capital

Target

KeTech

Nottingham, United Kingdom
KeTech provides real-time communication and information systems in the rail and transportation sectors. KeTech was founded in 1999 and is based in Nottingham, United Kingdom.

Search 214,356 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Investor(S) 2

Investor

Octopus Investments

London, United Kingdom

Investor Investor Investor Investor Investor


Category Asset Manager
Founded 2000
PE ASSETS 9.9B GBP
Size Mega
Type Sector Agnostic
DESCRIPTION

Octopus Investments is a private equity group that invests in lower middle-market UK based companies. Octopus looks to invest in buyouts, buy-ins, industry consolidations, and situations requiring development capital. Octopus' target investment size is £300k to £5 million in sectors such as business services, food/beverage, education and training, environmental services, media, marketing, healthcare, consumer, retail, leisure, and manufacturing. The Firm seeks businesses with a sustainable competitive advantage, whether through a unique product, IP, brand names or trade marks. Octopus Private Equity was formed in 2004 and is based in London.


DEAL STATS #
Overall 23 of 71
Sector: Technology Hardware M&A 2 of 8
Type: Growth Capital M&A Deals 4 of 18
Country: United Kingdom M&A 21 of 64
Year: 2009 M&A 5 of 8
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2009-06-09 Calastone

London, United Kingdom

Calastone is a global funds network, that connects the world’s major financial organizations. Calastone's mission is to help the asset management industry transform by creating innovative new ways to automate and digitalize the global investment funds marketplace, reducing frictional costs, and lowering the operational risk to the benefit of all. Calastone was formed in 2007 and is based in London, England.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2009-08-24 Surrey NanoSystems

Newhaven, United Kingdom

Surrey NanoSystems' Vantablack product is a black coatings brand solving serious challenges in space, optics, automotive sensing and aesthetics. Vantablack is the blackest man-made substance on earth. It's so dark, it absorbs 99.96% of light. Surrey NanoSystems was founded in 2006 and is based in Newhaven, United Kingdom.

Buy -
Investor

YFM Equity Partners

Leeds, United Kingdom

Investor Investor Investor Investor Investor


Category Private Equity Firm
Founded 1982
PE ASSETS 300M GBP
Size Middle-Market
Type Sector Agnostic
DESCRIPTION

YFM Equity Partners is a private equity firm focused on growth oriented investments in UK-based companies. The Firm looks to invest up to £10 million to support a variety of established, growing, and profitable businesses. YFM Equity Partners was formed in 1982 and is based in Leeds, England.


DEAL STATS #
Overall 22 of 91
Sector: Technology Hardware M&A 1 of 2
Type: Growth Capital M&A Deals 9 of 38
Country: United Kingdom M&A 22 of 90
Year: 2009 M&A 1 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2009-04-08 Tepnel Life Sciences

Wythenshawe, United Kingdom

Tepnel Life Sciences is a UK-based international life sciences products and services group with two divisions, Molecular Diagnostics and Research Products & Services.

Sell £93M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2009-09-22 DxS

Manchester, United Kingdom

DxS Ltd. is a personalized healthcare company providing molecular diagnostics to aid doctors and drug companies in selecting safe and effective therapies for patients based on their molecular profiles (Companion diagnostics). DxS was formed in 2001 and is headquartered in Manchester, UK.

Sell $130M